T1	HMM 121 140	Economic evaluation
T2	HMM 681 711	Costs of initial and follow-up
T3	HMM 781 800	economic evaluation
T4	HMM 826 836	efficacies
T5	HMM 865 889	primary outcome variable
T6	HMM 893 980	symptomatic, sustained ventricular tachyarrhythmia recurrence (including sudden death).
T7	HMM 989 1012	Initial hospitalization
T8	HMM 1044 1050	costly
T9	HMM 1220 1244	follow-up hospital costs
T10	HMM 1328 1348	total hospital costs
T11	HMM 1453 1550	two-year actuarial probability of a recurrent, sustained, symptomatic ventricular tachyarrhythmia
T12	HMM 1679 1701	initial hospital costs
T13	HMM 1752 1768	follow-up costs.
T14	HMM 1790 1795	costs
T15	HMM 1848 1871	antiarrhythmic efficacy
T16	HMM 1950 1971	total hospital costs.
